| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SARIN RAVI YANG | 4.7% | $11,959,434 | 4,109,771 | Ravi Sarin | 26 Mar 2025 |
As of 30 Sep 2025, 106 institutional investors reported holding 33,859,364 shares of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI). This represents 39% of the company’s total 87,441,936 outstanding shares.
The largest institutional shareholders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) together control 35% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 5.2% | 4,545,245 | +6.2% | 0% | $15,862,905 |
| BlackRock, Inc. | 3.9% | 3,434,875 | +3.9% | 0% | $11,987,713 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.8% | 3,360,052 | 0% | 0.18% | $11,726,581 |
| CenterBook Partners LP | 3.1% | 2,704,650 | +278% | 0.47% | $9,439,229 |
| Balyasny Asset Management L.P. | 2.9% | 2,518,337 | 0% | 0.02% | $8,788,996 |
| Kanen Wealth Management LLC | 2.1% | 1,842,101 | 2.1% | $6,420,611 | |
| WEXFORD CAPITAL LP | 1.8% | 1,571,069 | +40% | 1.7% | $5,483,030 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,401,906 | +9.6% | 0% | $4,893,399 |
| STATE STREET CORP | 1.3% | 1,130,025 | +75% | 0% | $3,943,787 |
| UBS Group AG | 1.2% | 1,055,862 | +151% | 0% | $3,684,959 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 951,001 | +135% | 0% | $3,318,993 |
| TIFF ADVISORY SERVICES, LLC | 0.98% | 856,628 | -76% | 0.62% | $2,989,632 |
| RENAISSANCE TECHNOLOGIES LLC | 0.86% | 750,500 | +64% | 0% | $2,619,245 |
| GOLDMAN SACHS GROUP INC | 0.78% | 681,643 | +341% | 0% | $2,378,934 |
| Manatuck Hill Partners, LLC | 0.72% | 629,800 | +152% | 0.75% | $2,198,002 |
| NORTHERN TRUST CORP | 0.53% | 464,692 | +13% | 0% | $1,621,775 |
| Massar Capital Management, LP | 0.46% | 400,000 | 0% | 0.5% | $1,396,000 |
| FourWorld Capital Management LLC | 0.41% | 358,000 | -8.6% | 3% | $1,249,420 |
| TWO SIGMA INVESTMENTS, LP | 0.32% | 278,967 | +0.29% | 0% | $973,595 |
| LPL Financial LLC | 0.31% | 266,985 | 0% | $931,778 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.28% | 247,884 | 0.02% | $865,115 | |
| EHP Funds Inc. | 0.28% | 244,041 | 1.1% | $851,703 | |
| FreeGulliver LLC | 0.24% | 210,000 | -39% | 0.33% | $732,900 |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 0.23% | 204,250 | -92% | 0.57% | $712,833 |
| NKCFO LLC | 0.22% | 190,000 | 0.2% | $663,000 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 98,304 | $349,516 | -$65,890 | $3.56 | 5 |
| 2025 Q3 | 33,859,364 | $118,161,510 | +$9,179,341 | $3.49 | 106 |
| 2025 Q2 | 31,474,503 | $64,523,702 | +$31,211,552 | $2.05 | 78 |
| 2025 Q1 | 16,901,932 | $19,267,414 | +$2,727,938 | $1.14 | 42 |
| 2024 Q4 | 14,712,600 | $4,608,917 | -$2,191,797 | $0.31 | 30 |
| 2024 Q3 | 20,589,694 | $6,982,762 | +$385,704 | $0.33 | 34 |
| 2024 Q2 | 18,701,866 | $8,832,828 | -$155,334 | $0.46 | 38 |
| 2024 Q1 | 17,222,037 | $27,535,675 | -$2,492,260 | $1.58 | 44 |
| 2023 Q4 | 18,436,129 | $37,608,749 | +$6,554,810 | $2.04 | 44 |
| 2023 Q3 | 15,107,160 | $21,169,015 | +$1,157,191 | $1.40 | 36 |
| 2023 Q2 | 13,916,345 | $7,656,692 | -$4,490,020 | $0.55 | 37 |
| 2023 Q1 | 21,905,923 | $14,849,314 | -$1,309,674 | $0.68 | 37 |
| 2022 Q4 | 23,473,725 | $38,730,078 | -$1,269,944 | $1.65 | 37 |
| 2022 Q3 | 23,327,364 | $108,006,612 | +$6,672,135 | $4.63 | 39 |
| 2022 Q2 | 21,874,386 | $110,684,000 | +$2,844,383 | $5.06 | 33 |
| 2022 Q1 | 17,791,143 | $126,852,000 | -$752,294 | $7.13 | 27 |
| 2021 Q4 | 21,118,138 | $199,883,000 | +$185,679,000 | $9.75 | 21 |
| 2021 Q3 | 252,439 | $2,504,000 | +$2,504,000 | $9.92 | 1 |